RecruitingEarly Phase 1NCT06645808

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Studying Chondrosarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Var2 Pharmaceuticals
Principal Investigator
Gooitzen van Dam, MD, PhD, M.D
TRACER Europe B.V.
Intervention
89Zr-DFO-N-Suc-F8scFv(biological)
Enrollment
32 enrolled
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Collaborators

TRACER Europe BV

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06645808 on ClinicalTrials.gov

Other trials for Chondrosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Chondrosarcoma

← Back to all trials